
Sun Jae Yoo
Examiner (ID: 4021, Phone: (571)272-9074 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1622, 1609, 1626, 1621 |
| Total Applications | 1924 |
| Issued Applications | 1172 |
| Pending Applications | 219 |
| Abandoned Applications | 564 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19691161
[patent_doc_number] => 20250009706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING OPIOID DEPENDENCE AND WITHDRAWAL
[patent_app_type] => utility
[patent_app_number] => 18/580474
[patent_app_country] => US
[patent_app_date] => 2022-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12700
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18580474
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/580474 | COMPOSITIONS AND METHODS FOR TREATING OPIOID DEPENDENCE AND WITHDRAWAL | Jul 17, 2022 | Pending |
Array
(
[id] => 19265251
[patent_doc_number] => 20240208950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF CERVICAL AND OVARIAN CANCER
[patent_app_type] => utility
[patent_app_number] => 18/292049
[patent_app_country] => US
[patent_app_date] => 2022-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14426
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18292049
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/292049 | COMPOSITIONS AND METHODS FOR TREATMENT OF CERVICAL AND OVARIAN CANCER | Jul 6, 2022 | Pending |
Array
(
[id] => 18449401
[patent_doc_number] => 20230190677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING AGING-RELATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/858233
[patent_app_country] => US
[patent_app_date] => 2022-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17858233
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/858233 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING AGING-RELATED DISEASES | Jul 5, 2022 | Abandoned |
Array
(
[id] => 19990024
[patent_doc_number] => 20250128246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-24
[patent_title] => MULTILAYER CATALYTIC BED FOR THE PRODUCTION OF PHTHALIC ANHYDRIDE
[patent_app_type] => utility
[patent_app_number] => 18/682663
[patent_app_country] => US
[patent_app_date] => 2022-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3463
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18682663
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/682663 | MULTILAYER CATALYTIC BED FOR THE PRODUCTION OF PHTHALIC ANHYDRIDE | Jul 4, 2022 | Pending |
Array
(
[id] => 18306222
[patent_doc_number] => 20230110122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => COMPOUNDS AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 17/810367
[patent_app_country] => US
[patent_app_date] => 2022-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29277
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17810367
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/810367 | Compounds and their use | Jun 30, 2022 | Issued |
Array
(
[id] => 18163259
[patent_doc_number] => 20230029852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => METHOD FOR THE SYNTHESIS OF 3-R-1,4,2-DIOXAZOL-5-ONES
[patent_app_type] => utility
[patent_app_number] => 17/855414
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6938
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17855414
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/855414 | Method for the synthesis of 3-R-1,4,2-dioxazol-5-ones | Jun 29, 2022 | Issued |
Array
(
[id] => 18391317
[patent_doc_number] => 20230159535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => CDK2 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/850453
[patent_app_country] => US
[patent_app_date] => 2022-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17850453
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/850453 | CDK2 inhibitors | Jun 26, 2022 | Issued |
Array
(
[id] => 18213434
[patent_doc_number] => 20230059698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => Method of Manufacture for Liquid Cannabinoids, and Modified CBD Oil Composition
[patent_app_type] => utility
[patent_app_number] => 17/845499
[patent_app_country] => US
[patent_app_date] => 2022-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17845499
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/845499 | Method of Manufacture for Liquid Cannabinoids, and Modified CBD Oil Composition | Jun 20, 2022 | Abandoned |
Array
(
[id] => 18109496
[patent_doc_number] => 20230002376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => BICYCLIC PYRAZOLYL AMINES AS CDK2 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/845142
[patent_app_country] => US
[patent_app_date] => 2022-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44295
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -59
[patent_words_short_claim] => 3852
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17845142
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/845142 | Bicyclic pyrazolyl amines as CDK2 inhibitors | Jun 20, 2022 | Issued |
Array
(
[id] => 18221360
[patent_doc_number] => 20230060354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => DIACYLGLYERCOL KINASE MODULATING COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/845534
[patent_app_country] => US
[patent_app_date] => 2022-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87118
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17845534
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/845534 | Diacylglycerol kinase modulating compounds | Jun 20, 2022 | Issued |
Array
(
[id] => 19210685
[patent_doc_number] => 11999733
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-04
[patent_title] => Diacylglycerol kinase modulating compounds
[patent_app_type] => utility
[patent_app_number] => 17/844921
[patent_app_country] => US
[patent_app_date] => 2022-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69742
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17844921
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/844921 | Diacylglycerol kinase modulating compounds | Jun 20, 2022 | Issued |
Array
(
[id] => 20187032
[patent_doc_number] => 12398137
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-26
[patent_title] => Compositions providing slow release of caffeine
[patent_app_type] => utility
[patent_app_number] => 17/843197
[patent_app_country] => US
[patent_app_date] => 2022-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 28
[patent_no_of_words] => 8136
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17843197
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/843197 | Compositions providing slow release of caffeine | Jun 16, 2022 | Issued |
Array
(
[id] => 18140216
[patent_doc_number] => 20230014055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => Treatment of Immune-Related Disorders, Kidney Disorders, Liver Disorders, Hemolytic Disorders, and Oxidative Stress-Associated Disorders Using NRH, NARH and Reduced Derivatives Thereof
[patent_app_type] => utility
[patent_app_number] => 17/842158
[patent_app_country] => US
[patent_app_date] => 2022-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31378
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17842158
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/842158 | Treatment of Immune-Related Disorders, Kidney Disorders, Liver Disorders, Hemolytic Disorders, and Oxidative Stress-Associated Disorders Using NRH, NARH and Reduced Derivatives Thereof | Jun 15, 2022 | Abandoned |
Array
(
[id] => 19196383
[patent_doc_number] => 11993610
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-28
[patent_title] => BCL-2 inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/840957
[patent_app_country] => US
[patent_app_date] => 2022-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25575
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17840957
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/840957 | BCL-2 inhibitors | Jun 14, 2022 | Issued |
Array
(
[id] => 19394905
[patent_doc_number] => 20240284775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => ORGANOMETALLIC COMPOUND AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/289449
[patent_app_country] => US
[patent_app_date] => 2022-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9974
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 446
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18289449
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/289449 | ORGANOMETALLIC COMPOUND AND APPLICATION THEREOF | Jun 10, 2022 | Pending |
Array
(
[id] => 19860637
[patent_doc_number] => 20250099423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-27
[patent_title] => PIPERAZINE-BASED AGONISTS OF LFA-1 AND VLA-4
[patent_app_type] => utility
[patent_app_number] => 18/682681
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15061
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18682681
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/682681 | PIPERAZINE-BASED AGONISTS OF LFA-1 AND VLA-4 | Jun 8, 2022 | Pending |
Array
(
[id] => 17882686
[patent_doc_number] => 20220298163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => BTK INHIBITORS WITH IMPROVED DUAL SELECTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/828643
[patent_app_country] => US
[patent_app_date] => 2022-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21041
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17828643
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/828643 | BTK INHIBITORS WITH IMPROVED DUAL SELECTIVITY | May 30, 2022 | Abandoned |
Array
(
[id] => 18139339
[patent_doc_number] => 20230013175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => ORAL AQUEOUS SUSPENSION FORMULATION COMPRISING CARBAMATE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/826289
[patent_app_country] => US
[patent_app_date] => 2022-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17826289
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/826289 | Oral aqueous suspension formulation comprising carbamate compound | May 26, 2022 | Issued |
Array
(
[id] => 19402087
[patent_doc_number] => 20240285598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => COMPOUNDS FOR THE TREATMENT OF SARS
[patent_app_type] => utility
[patent_app_number] => 18/564748
[patent_app_country] => US
[patent_app_date] => 2022-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14908
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18564748
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/564748 | COMPOUNDS FOR THE TREATMENT OF SARS | May 26, 2022 | Pending |
Array
(
[id] => 19343702
[patent_doc_number] => 20240252665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => CHEMICAL COUPLING LINKER AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/559039
[patent_app_country] => US
[patent_app_date] => 2022-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18559039
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/559039 | CHEMICAL COUPLING LINKER AND USE THEREOF | May 22, 2022 | Pending |